PT  - JOURNAL ARTICLE
AU  - Yves Lacourcière
AU  - Luc Poirier
TI  - Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes
AID  - 10.1136/ebm1412
DP  - 2011 Aug 01
TA  - Evidence Based Medicine
PG  - 122--123
VI  - 16
IP  - 4
4099  - http://ebm.bmj.com/content/16/4/122.short
4100  - http://ebm.bmj.com/content/16/4/122.full
SO  - Evid Based Med2011 Aug 01; 16